Follicular lymphoma: open trials in Spain

21 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07249905
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Trial Treatment · Phase 1/2 · ModeX Therapeutics, An OPKO Health Company
Virgen del Rocio University Hospital, Seville
Registry updated 2026-11-06
NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala d'Oncologia - L'Hospitalet, Barcelona · Hospital Universitario Vall d'Hebron, Barcelona · South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid
Registry updated 2026-11-04
NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-11-04
NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
Institut Catala D'Oncologia, Badalona · Hospital Universitario Quirónsalud Madrid, Madrid · Hospital Clinico Universitario de Salamanca, Salamanca
Registry updated 2026-11-03
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-02
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga
Registry updated 2026-10-29
NCT07634471
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Complejo Asistencial Universitario de Salamanca, Salamanca
Registry updated 2026-10-26
NCT06549595
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Trial Treatment · Phase 3 · AstraZeneca
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Català d'Oncologia, Girona · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Central De Asturias, Oviedo · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-10-21
NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Trial Treatment · Phase 1 · Pfizer
Hospital Clinic de Barcelona, Barcelona · Hospital Quirónsalud Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Consorcio Hospitalario Provincial De Castellon, Castello De La Plana · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Clínico San Carlos, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-15
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Registry updated 2026-10-14
NCT06149286
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Virgen de las Nieves, Granada · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Central De Asturias, Oviedo · University Hospital Son Espases, Palma · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Dr. Peset Aleixandre, Valencia · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-10-07
NCT06091254
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Complejo Hospitalario Universitario de A Coruña, A Coruña · Cruces University Hospital (Hospital Universitario Cruces), Barakaldo · University Hospital Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar · Hospital Virgen De Las Nieves De Granada, Granada · Gregorio Maranon, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario HM Sanchinarro, Servicio de Hematologia, Madrid · Fundación Jiménez Díaz University Hospital, Madrid · University Hospital & Research Institute, Madrid · Hospital Universitario Virgen De La Victoria Malaga, Málaga · Morales Meseguer Hospital, Murcia · Complexo Hospitalario Universitario de Ourense, Ourense · Hospital Universitario Central De Asturias, Oviedo · Son Espases University Hospital, Palma · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital of Santiago de Compostela, Santiago de Compostela · University Hospital Virgen del Rocio, Seville · Hospital Universitario Virgen Macarena, Seville · Hospital Universitario Virgen de Valme, Seville · Hospital General Universitario de Toledo, Toledo · Hospital Clinico Universitario Valencia, Valencia · Hospital Universitari and Politecnic La Fe, Valencia · Hospital Clinico Lozano Blesa, Zaragoza
Registry updated 2026-10-06
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Hospital Universitario Vall Dhebron, Barcelona · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Md Anderson Cancer Center Madrid Spain, Madrid · Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-05
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Barcelona · L'Hospitalet de Llobregat · Madrid
Registry updated 2026-09-30
NCT06980116
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Trial Treatment · Phase 1 · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · MD Anderson Cancer Center, Madrid · Hospital Beata María Ana, Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-08-13
NCT05131022
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Trial Treatment · Phase 1 · Nurix Therapeutics, Inc.
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario de Cabueñes, Gijón · Hospital Ramón y Cajal, Madrid · Hospital Fundación Jimenez Díaz - START Madrid, Madrid
Registry updated 2026-07-02
NCT04844866
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clinica Universidad de Navarra, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-06-10
NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Trial Treatment · Phase 3 · Celgene
Hospital Universitario Virgen de las Nieves, Granada · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Infanta Leonor, Madrid · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-05-20
NCT06830759
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Research · AbbVie
Complejo Hospitalario Universitario A Coruña /ID# 272040, A Coruña · Institut Català d'Oncologia (ICO) - Badalona /ID# 272043, Badalona · Hospital Universitario De Burgos /ID# 272066, Burgos · Hospital Universitario Reina Sofia /ID# 272051, Córdoba · Hospital de Manises /ID# 272046, Manises · Hospital Costa del Sol /ID# 272431, Marbella · Hospital General Universitario Morales Meseguer /ID# 272466, Murcia · Hospital Universitario de Navarra /ID# 272041, Pamplona · Hospital Universitari Parc Tauli /ID# 272044, Sabadell · Hospital Universitario Nuestra Señora de Candelaria /ID# 272413, Santa Cruz de Tenerife · Hospital Universitario de Valme /ID# 272050, Seville · Hospital Clinico Universitario de Valladolid /ID# 272042, Valladolid
Registry updated 2026-02-17
NCT05544019
Study of SGR-1505 in Mature B-Cell Neoplasms
Trial Treatment · Phase 1 · Schrödinger, Inc.
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-02-13
2024-519790-19-00
IMMUNOTHERAPY WITH DIFFERENTIATED T CELLS, ADULTS, AUTOLOGOUS, FROM PERIPHERAL BLOOD, SELECTED BY CD62L EXPRESSION, EXPANDED AND TRANSDUCED (GENETICALLY MODIFIED) THROUGH A LENTIVIRAL VECTOR TO EXPRESS A CHIMERIC RECEPTOR WITH ANTI-CD19 SPECIFICITY ASSOCIATED WITH CO-STIMULATORY SEQUENCES 4-1-BB AND CD3Ζ IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA.
Trial Treatment · Phase 1/2 · Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
Hospital de la Santa Creu i Sant Pau, Barcelona · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2025-09-29

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error